Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Lapatinib | 1 | uM | 9 | 5000.00 | 2099.14 | 11027.00 | 11908.75 | 0.9260 | 0.9395 |
| MCF 10A | 0 | uM | 9 | 5000.00 | 2099.14 | 11779.00 | 11908.75 | 0.9891 | 0.9913 | |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 126.00 | 206.25 | 0.6109 | 0.5923 | |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 156.25 | 46.09 | 139.00 | 206.25 | 0.6739 | 0.6663 |
| MCF 10A | 17-AAG | 0.000302 | uM | 9 | 156.25 | 46.09 | 176.00 | 206.25 | 0.8533 | 0.8585 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 165.00 | 206.25 | 0.8000 | 0.8039 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 156.25 | 46.09 | 42.00 | 206.25 | 0.2036 | -0.0421 |
| MCF 10A | Lapatinib | 10 | uM | 9 | 156.25 | 46.09 | 23.00 | 206.25 | 0.1115 | -0.2750 |
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 153.00 | 206.25 | 0.7418 | 0.7419 |
| MCF 10A | 17-AAG | 0.0001 | uM | 9 | 156.25 | 46.09 | 346.00 | 206.25 | 1.6776 | 1.5407 |
| MCF 10A | Erlotinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 374.00 | 206.25 | 1.8133 | 1.6339 |
| MCF 10A | Lapatinib | 1 | uM | 9 | 156.25 | 46.09 | 468.00 | 206.25 | 2.2691 | 1.9217 |
| MCF 10A | Linsitinib | 10 | uM | 9 | 156.25 | 46.09 | 73.00 | 206.25 | 0.3539 | 0.2370 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 63.00 | 206.25 | 0.3055 | 0.1555 |
| MCF 10A | Erlotinib | 10 | uM | 9 | 156.25 | 46.09 | 46.00 | 206.25 | 0.2230 | -0.0009 |
| MCF 10A | Linsitinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 247.00 | 206.25 | 1.1976 | 1.1740 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 285.00 | 206.25 | 1.3818 | 1.3227 |
| MCF 10A | 17-AAG | 0.01 | uM | 9 | 156.25 | 46.09 | 33.00 | 206.25 | 0.1600 | -0.1432 |
| MCF 10A | Lapatinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 198.00 | 206.25 | 0.9600 | 0.9626 |
| MCF 10A | 17-AAG | 0.001 | uM | 9 | 156.25 | 46.09 | 166.00 | 206.25 | 0.8049 | 0.8089 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 246.00 | 206.25 | 1.1927 | 1.1699 | |
| MCF 10A | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 46.09 | 169.00 | 206.25 | 0.8194 | 0.8240 |
| MCF 10A | Linsitinib | 1 | uM | 9 | 156.25 | 46.09 | 130.00 | 206.25 | 0.6303 | 0.6155 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 259.00 | 206.25 | 1.2558 | 1.2222 | |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 233.00 | 206.25 | 1.1297 | 1.1161 |